Clinical Trial Update: Use of Allogeneic Extracellular Secretomes (EV)Derived From Umbilical Cord Mesenchymal Stromal Cells: a Phase I Open-label Safety Trial. [Phase 1]

View source ↗

Summary

A Phase I open-label safety trial using allogeneic extracellular secretomes derived from umbilical cord mesenchymal stromal cells to treat vitiligo; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Allogeneic extracellular secretomes (EVs) derived from umbilical cord mesenchymal stromal cells

Snippet

Sponsor: University of Jordan | Conditions: Vitiligo | Phase 1 | Status: ACTIVE_NOT_RECRUITING